Poisonous sea snails could be carrying the next generation of pain killing drugs, spelling hope for more than three million Australians living with chronic pain, RMIT University research reveals.
RMIT scientists have helped identify the venoms from cone snails that could provide the pain killers of the future to treat chronic pain without risks of addiction or side-effects associated with some pharmaceuticals such as morphine.
The promising results from on-going trials involving RMIT scientists who have studied more than 700 species of cone snails suggest the next generation of pain relief medication could be found in the venom of the marine life.
Professor David Adams, director of RMIT’s Health Innovations Research Institute has studied the venom or conotoxins of sea snails. He presents his findings at the Symposium at the Bundoora campus today.
The international symposium for health and medical professionals and students has attracted leading researchers from around the world.
Among them are RMIT experts showcasing research highlights in healthcare – ranging from sleep disorders to Indigenous health risks, and understanding cognitive deficits in psychiatric illness.
The Evidence-Based Integrative Healthcare Symposium will canvass the latest research to help evaluate the effectiveness of healthcare interventions, particularly in relation to ageing populations and chronic disease.
Guest presenters and keynote speakers hail from prestigious health organisations including the World Health Organisation (WHO), the Baker IDI Heart and Diabetes Institute and the National Health and Medical Research Council.
What: Evidence-Based Integrative Healthcare Symposium
When: Thursday 16 July, 8.30am to 5.30pm
Where: RMIT Bundoora campus, Building 224 Auditorium, University Hill, 30 Janefield Drive, Bundoora.
For interviews: Professor Steve Robinson, Deputy Head of Research and Innovation, (03) 9925 7120.
For media enquiries: Elisabeth Tarica on 03) 9925 3176 or 0417 510 735.